Share chart Mainz Biomed N.V.
Extended chart
Simple chart
About Mainz Biomed N.V.
Mainz Biomed N.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics. It offers ColoAlert, a colorectal cancer screening stool-based deoxyribonucleic acid test; and PancAlert, a product candidate for a pancreatic cancer screening test. The company has a research collaboration with Microba Life Sciences to discover and develop novel therapeutics for major diseases. The company was founded in 2008 and is based in Mainz, Germany.Main settings
| IPO date | 2021-11-05 |
|---|---|
| ISIN | NL0015000LC2 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | link |
| Change price per day: | -2.39% (2.09) |
|---|---|
| Change price per week: | -2.39% (2.09) |
| Change price per month: | -44.86% (3.7) |
| Change price per 3 month: | -64.08% (5.68) |
| Change price per half year: | +696.88% (0.256) |
| Change price per year: | +168.42% (0.76) |
| Change price per 3 year: | -82.34% (11.55) |
| Change price per year to date: | -57.68% (4.82) |
Grade
Underestimation
| Title | Value | Grade |
|---|---|---|
| P/S | 4.68 | 3 |
| P/BV | 0.6918 | 10 |
| P/E | 0 | 0 |
Efficiency
| Title | Value | Grade |
|---|---|---|
| ROA, % | -151.15 | 0 |
| ROE, % | -465.82 | 0 |
| ROIC, % | 0 | 0 |
Dividends
| Title | Value | Grade |
|---|---|---|
| Dividend yield | 0 | 0 |
| DSI | 0 | 0 |
| Average dividend growth | 0 | 0 |
Debt
| Title | Value | Grade |
|---|---|---|
| Debt/EBITDA | -0.1673 | 10 |
| Debt/Ratio | 0.2471 | 10 |
| Debt/Equity | 1.19 | 8 |
Growth impulse
| Title | Value | Grade |
|---|---|---|
| Yield Revenue, % | 80.97 | 9 |
| Yield Ebitda, % | 7280.53 | 10 |
| Yield EPS, % | 45073.7 | 10 |
Main owners
| Institutions | Volume | Share, % |
|---|---|---|
| Prelude Capital Management LLC | 75 000 | 0.43 |
| Citadel Advisors Llc | 33 244 | 0.19 |
| Northern Trust Corporation | 33 082 | 0.19 |
| Morgan Stanley | 32 045 | 0.18 |
| Geode Capital Management, LLC | 15 189 | 0.09 |
| Vontobel Holding Limited | 14 000 | 0.08 |
| XTX Topco Ltd | 13 850 | 0.08 |
| Greenwich Investment Management, Inc. | 13 784 | 0.08 |
| NewEdge Advisors, LLC | 1 000 | 0.01 |
| Citigroup Inc. | 673 | 0 |
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Guido Baechler | CEO & Executive Director | N/A | 1965 (60 years) |
| Mr. William J. Caragol | Chief Financial Officer | N/A | 1967 (58 years) |
| Dr. Frank Krieg-Schneider | Chief Technology Officer | N/A | 1962 (63 years) |
| Dr. Moritz Eidens Ph.D. | Chief Science Officer & Executive Director | N/A | 1984 (41 year) |
| Stefan Erlach | Head of Human Resources | N/A | |
| Mr. Philipp Freese | Chief Business Officer | N/A | 1983 (42 years) |
| Dr. Christopher Von Torne P.M.P., Ph.D. | Chief Operating Officer | N/A | 1972 (53 years) |
About company
Address: Germany, Mainz, Robert Koch Strasse 50 - Open in google maps, Open in yandex maps
Website: https://mainzbiomed.com
Website: https://mainzbiomed.com
